[The xanthines: status in the therapeutic arsenal in 1990].
Methylxanthines are at present widely prescribed for obstructive airway-diseases. However, the exact therapeutic role of these drugs is not clear in 1990. In this short review, we discuss what we think to be a rational use of xanthines in asthma and in COPD patients: shortly speaking, we propose that the drugs are not first-line therapeutic tools and should be only prescribed in selected situations.
Chevrolet
J C
JC
Div. pneumologie et soins intensifs médicaux, Hôpital cantonal universitaire, Genève.
D001249:Asthma / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D014970:Xanthines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D014970:Xanthines; C008514:methylxanthine
Les xanthines: situation dans l'arsenal thérapeutique en 1990.